Fig. 7 | Scientific Reports

Fig. 7

From: Lactobacillus lysates protect oral epithelial cells from pathogen-associated damage, increase secretion of pro-inflammatory cytokines and enhance barrier integrity

Fig. 7

Trans-epithelial electrical resistance (TEER). TR146 cells treated with 100 µg/mL of pathogenic or probiotic lysate (A) or a combination of 50 µg/mL of probiotic lysate and 50 µg/mL PG supernatant (B). PBS represents cells where treatment was replaced by DPBS. PG_sn (B) represents cells treated with 50 µg/mL PG supernatant and DPBS in place of probiotics. Porphyromonas gingivalis (PG), Fusobacterium nucleatum (FN), Aggregibacter actinomycetemcomitans (AA), Lactobacillus rhamnosus (SD), Lactobacillus plantarum (LP), Lactobacillus reuteri (LR). (n = 3) Lactobacillus rhamnosus (GG) n = 6 (A) n = 3 (B). Time-course data from after treatment has been added to boxplots in a non-time dependent manner. One-way ANOVA *(p < 0.05), **(p < 0.01), ***(p < 0.001), ****(p < 0.0001).

Back to article page